More News
29 March 2018
Indivior Enters Into an Exclusive Global License Agreement for C4X Discovery’s Orexin-1 (OX1) Antagonist Program26 March 2018
Shire and NanoMedSyn Enter Into Research Agreement for Potential Lysosomal Storage Disorder Treatment22 March 2018
CBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 Antibody20 March 2018
Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies16 March 2018
Bavarian Nordic Announces Partnership with U.S. Department of Defense to Combat Equine Encephalitis Virus16 March 2018
Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer14 March 2018
AveXis Enters into Licensing Agreement with GenethonNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports